Novartis ’ Kymriah receives FDA approval for B-cell precursor ALL treatment
The US Food and Drug Administration (FDA) has approved Novartis ’ Kymriah (tisagenlecleucel) suspension for intravenous infusion to treat patients up to 25 years of age with B-cell precursor acute lymphoblastic leukaemia (ALL) that is refractory or in… (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - August 31, 2017 Category: Pharmaceuticals Source Type: news

M & As this week: Merck KGaA, Genius Lead, Sanofi
German science and technology company Merck KGaA plans to acquire Canadian hydrogel membrane products provider Natrix Separations. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - August 31, 2017 Category: Pharmaceuticals Source Type: news

Daiichi Sankyo to end agreement with Charleston Laboratories for hydrocodone products
Daiichi Sankyo has elected to terminate its existing agreement with Charleston Laboratories to forgo the development and commercialisation of hydrocodone products in the US for the treatment of moderate-to-severe acute pain and to reduce opioid-induc … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - August 31, 2017 Category: Pharmaceuticals Source Type: news

Temperature Sensitive Shipping Products
Cedarlane Shipping Supplies provides temperature-sensitive shipping products such as thick and thin wall foam containers with or without printed outer corrugate boxes, gel packs, and foam packs. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - August 31, 2017 Category: Pharmaceuticals Source Type: news

European Commission licences EUSA ’s advanced RCC treatment fotivda
Jazz Pharmaceuticals subsidiary EUSA Pharma ’s fotivda (tivozanib) has been licensed by the European Commission (EC) for first-line treatment of adult patients with advanced renal cell carcinoma (RCC). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - August 30, 2017 Category: Pharmaceuticals Source Type: news

New study reveals role of proteins in treating bowel cancer
A new bowel cancer study conducted by the UK ’s Wellcome Trust Sanger Institute has revealed the impact of mutations on protein networks. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - August 30, 2017 Category: Pharmaceuticals Source Type: news

EMA accepts Pfizer ’s bosulif Type II Variation application for Ph+ CML
The European Medicines Agency (EMA) has approved for review a Type II Variation application for the use of Pfizer ’s bosulif (bosutinib) to treat patients with Philadelphia chromosome-positive (Ph+) chronic myeloid leukaemia (CML). (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - August 30, 2017 Category: Pharmaceuticals Source Type: news

Zenith Technologies-Delivering Pharmaceutical Manufacturing Execution Systems (MES), Automation, and Process Control
Zenith Technologies produces software systems for the life sciences industry, specialising in delivering manufacturing execution systems (MES), automation, and process control solutions for the management and control of manufacturing plants to improv … (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - August 30, 2017 Category: Pharmaceuticals Source Type: news

Antibe Therapeutics Approved to Conduct Phase II Trial for ATB-346
Antibe Therapeutics has announced that it has received approval from Health Canada to initiate a Phase 2, double-blind, gastrointestinal endoscopy trial for its lead drug ATB-346. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - August 30, 2017 Category: Pharmaceuticals Source Type: news

Pharmaceutical Development Group to Attend AAPS
Pharmaceutical Development Group has announced it will be attending this year's AAPS Annual Meeting and Exposition in San Diego. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - August 30, 2017 Category: Pharmaceuticals Source Type: news

FDA approves AstraZeneca ’s faslodex for expanded use in breast cancer
AstraZeneca ’s faslodex (fulvestrant) at 500mg has received approval from the US Food and Drug Administration (FDA) as monotherapy for expanded use in women with advanced breast cancer. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - August 29, 2017 Category: Pharmaceuticals Source Type: news

Watson-Marlow Fluid Technology Group-Peristaltic Pumps, Tubes, and Hoses for the Pharmaceutical Industry
Watson-Marlow Fluid Technology Group (WMFTG) provides biopharmaceutical, diagnostics, and pharmaceutical industries with specialised peristaltic pumps and fluid path technologies for research applications. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - August 29, 2017 Category: Pharmaceuticals Source Type: news

ImmunoGen and Jazz collaborate to develop and market ADC products
ImmunoGen has entered a collaboration and option agreement to grant exclusive worldwide rights to Jazz Pharmaceuticals for the development and commercialisation of two haematology-related antibody-drug conjugate (ADC) candidates, IMGN779 and IMGN632. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - August 29, 2017 Category: Pharmaceuticals Source Type: news

Seattle Genetics exercises option to co-develop tisotumab vedotin for solid tumours
Danish biotechnology company Genmab and US-based Seattle Genetics are set to co-develop tisotumab vedotin for the treatment of patients with solid tumours. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - August 29, 2017 Category: Pharmaceuticals Source Type: news

GE Healthcare's Investment in Zenith Technologies
In April this year, GE Healthcare Life Sciences announced that GE completed a strategic minority investment in Irish-owned Zenith Technologies. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - August 29, 2017 Category: Pharmaceuticals Source Type: news